mevalonic acid

Mevalonic acid is essential for cell growth and proliferation,Mevalonic acid is a precursor in the mevalonate pathway.

L-Mevalonic acid ((S)-Mevalonic acid), a distant precursor of cholesterol, is a metabolite of the mevalonic acid pathway and is used in the study of autoimmune diseases, atherosclerosis and Alzheimer's disease.

Mevalonic acid 5-pyrophosphate (also known as 5-Diphosphomevalonic acid) tetralithium is an endogenous metabolite involved in the mevalonate pathway.

(R)-Mevalonic acid ((R)-MVA) sodium is an isomer of Mevalonic acid. Mevalonic acid (MVA) serves as a precursor in the mevalonate pathway, which is crucial for cellular growth and proliferation.

Mevalonic acid lithium salt (MVA lithium salt) is a precursor of the mevalonic acid pathway, an initiator of cell growth, a key substance in cholesterol synthesis, and stimulates DNA synthesis, morphology transformation, and cell cycling in human lymphocytes from peripheral blood.

D,L-Mevalonic acid dicyclohexylammonium is a reagent used in biochemical reactions.

DL-Mevalonolactone-D7 is the deuterated form of DL-Mevalonolactone. DL-Mevalonolactone (T1353) ( (±)-Mevalonolactone; Mevalolactone) represents the δ-lactone form of mevalonic acid and serves as a precursor in the mevalonate pathway. It has the capability to reduce mitochondrial membrane potential (∆Ψm), NAD (P)H content, and the calcium ion (Ca2+) retention capacity in the brain.

DL-Mevalonolactone-d4 ((±)-Mevalonolactone-d4) is a deuterium-labeled form of DL-Mevalonolactone. This compound, also known as (±)-Mevalonolactone or Mevalolactone, is the δ-lactone form of mevalonic acid and serves as a precursor in the mevalonate pathway. DL-Mevalonolactone is orally active against myopathy caused by HMGCR mutations and statins. Additionally, it induces inflammatory and oxidative stress responses, reduces mitochondrial membrane potential, and causes mitochondrial swelling.